miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis Virus Infection by Targeting Ulk1

被引:17
|
作者
Li, Zi [1 ]
Lan, Yungang [1 ]
Zhao, Kui [1 ]
Lv, Xiaoling [1 ]
Ding, Ning [1 ]
Lu, Huijun [2 ]
Zhang, Jing [1 ]
Yue, Huiqing [1 ]
Shi, Junchao [1 ]
Song, Deguang [1 ]
Gao, Feng [1 ]
He, Wenqi [1 ]
机构
[1] Jilin Univ, Coll Vet Med, Key Lab Zoonosis, Minist Educ, Changchun, Peoples R China
[2] Jilin Univ, Inst Zoonosis, Key Lab Zoonosis, Minist Educ, Changchun, Peoples R China
基金
中国国家自然科学基金;
关键词
Porcine hemagglutinating encephalomyelitis virus; neurotropic virus; miR-142-5p; Ulk1; neuronal morphogenesis; GENE-EXPRESSION; MESSENGER-RNAS; MICRORNA; CORONAVIRUS; GENOME; GROWTH; IDENTIFICATION; NEUROTROPISM; BIOGENESIS; MECHANISM;
D O I
10.3389/fcimb.2017.00155
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Porcine hemagglutinating encephalomyelitis virus (PHEV) invades the central nervous system (CNS) and causes neurodegenerative disease in suckling piglets, but the understanding of its neuropathogenicity for neurological dysfunction remains limited. Here, we report that miR-142-5p is localized to neurons and negatively regulates neuronal morphogenesis in porcine hemagglutinating encephalomyelitis (PHE). This phenotype was mediated by miR-142-5p inhibition of an mRNA encoding unc-51-like-kinase1 (Ulk1), which controls axon outgrowth and dendrite formation. Modulating miR-142-5p activity by microRNA mimics or inhibitors induced neurodegeneration, including stunted axon elongation, unstable dendritic spine formation, and irregular swelling and disconnection in neurites. Relieving Ulk1 mRNA repression in primary cortical neurons by miR-142-5p antagomirs or replication-deficient adenoviruses encoding Ulk1 (Ad5-Ulk1), which improved rescue of nerve injury, restricted viral replication, and increased survival rate in mice underlying PHEV infection. In contrast, disrupting Ulk1 in RNAi-expressing neurons mostly led to significantly shortened axon elongation and/or an abnormally large number of branched dendrites. Taken together, we demonstrated that the abnormal neuronal morphogenesis underlying PHEV infection was mainly caused by functional mRNA repression of the miR-142-5p target Ulk1. Our data revealed that PHEV adapted to use spatiotemporal control of host microRNAs to invade CNS, and provided new insights into the virus-associated neurological dysfunction microenvironment.
引用
收藏
页数:15
相关论文
共 35 条
  • [31] Silencing of circ-NT5C2 retards the progression of IL-1β-induced osteoarthritis in an in vitro cell model by targeting the miR-142-5p/NAMPT axis
    Zhang, Wei
    Wang, Yan-dong
    Xing, Yong-jun
    Liu, Peng-jun
    Yang, Jian-hui
    MICROBIOLOGY AND IMMUNOLOGY, 2023, 67 (03) : 129 - 141
  • [32] Circular RNA RRM2 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miR-142-5p to increase NRG1 expression
    Wu, Long-Fei
    Zhou, Zhi-Jiang
    Zeng, Yu-Heng
    Yang, Sheng-Li
    Zhang, Qing-Ying
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2024, 327 (04): : G485 - G498
  • [33] miR-142-5p in Bone Marrow-Derived Mesenchymal Stem Cells Promotes Osteoporosis Involving Targeting Adhesion Molecule VCAM-1 and Inhibiting Cell Migration
    Teng, Zhaowei
    Xie, Xueguan
    Zhu, Yun
    Liu, Jianping
    Hu, Xingbo
    Na, Qiang
    Zhang, Xiongwen
    Wei, Guojun
    Xu, Shen
    Liu, Yugang
    Zhang, Xiguang
    Xian, Cory J.
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [34] MiR-139-5p protect against myocardial ischemia and reperfusion (I/R) injury by targeting autophagy-related 4D and inhibiting AMPK/mTOR/ULK1 pathway
    Wang, Yingcui
    Sun, Hui
    Song, Jun
    Yao, Guihua
    Sun, Huibo
    Ge, Zhiming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09): : 10140 - 10151
  • [35] miR-142-5p suppresses proliferation and promotes apoptosis of human osteosarcoma cell line, HOS, by targeting PLA2G16 through the ERK1/2 signaling pathway
    Cheng, Deliang
    Li, Jiageng
    Zhang, Lijun
    Hu, Leiming
    ONCOLOGY LETTERS, 2019, 17 (01) : 1363 - 1371